EIF2A and amyotrophic lateral sclerosis: Interestingly, sephin 1, which promotes eIF2α dephosphorylation, and guanabenz, which blocks eIF2α dephosphorylation, both provided neuroprotection in ALS models despite presenting opposite mechanisms of action [289,290].